BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2730560
Number of visits today
816
Number of downloads
2001523
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Tondepu C, Karumbaiah L. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma. Adv Healthc Mater 2022;11:e2101956. [PMID: 34878733 DOI: 10.1002/adhm.202101956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sallam M, Mysara M, Baatout S, Guns PJ, Ramadan R, Benotmane MA. Meta-Analysis of RNA-Seq Datasets Identifies Novel Players in Glioblastoma. Cancers (Basel) 2022;14. [PMID: 36497269 DOI: 10.3390/cancers14235788] [Reference Citation Analysis]
2 Lin S, Tan Z, Cui H, Ma Q, Zhao X, Wu J, Dai L, Kang H, Guan F, Dai Z. Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer. Front Oncol 2022;12:854284. [DOI: 10.3389/fonc.2022.854284] [Reference Citation Analysis]
3 Silsirivanit A. Glycan and Glycosylation as a Target for Treatment of Glioblastoma. Glioblastoma - Current Evidences [Working Title] 2022. [DOI: 10.5772/intechopen.106044] [Reference Citation Analysis]
4 Xie Y, Lu X, Wang Z, Liu M, Liu L, Wang R, Yang K, Xiao H, Li J, Tang X, Liu H. A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma. Biomater Sci 2022. [DOI: 10.1039/d2bm01145j] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345